Rubicon Genomics Snapshot
Rubicon Genomics intends to be the premier provider of platforms for the pre-analytical amplification of nucleic acid for research and clinical applications. Our technologies’ simple protocols, fast time to results and unique ability to amplify nucleic acid from “difficult” samples differentiate our products and enable researchers and healthcare providers to more easily and cost-effectively realize the benefits of the genomic revolution
Rubicon Genomics is a growing, profitable company located in Ann Arbor, MI. Our innovative products combined with our partnerships have established us as a leader in pre-analytical amplification technologies. Our competencies, include enzymology, nucleic acid chemistry, sample processing and manufacturing, have served as engines for innovation, development of our IP, and ongoing product development in next generation sequencing.
In 2014 we delivered a 28% increase in sales growth.
Our partnerships with the academic community and our customers has resulted in a robust pipeline of future products. Our products break the sample barriers for our customers allowing use of less sample from a diverse set of sample sources. Each of our test kits is constructed for ease of use, robustness, and speed to results. Our products are available for research and clinical use. We are recruiting scientists and other professionals throughout this year to support that growth and to introduce new products.
In 2014 we delivered a 28% increase in sales growth.
Our partnerships with the academic community and our customers has resulted in a robust pipeline of future products. Our products break the sample barriers for our customers allowing use of less sample from a diverse set of sample sources. Each of our test kits is constructed for ease of use, robustness, and speed to results. Our products are available for research and clinical use. We are recruiting scientists and other professionals throughout this year to support that growth and to introduce new products.
